MEXILETINE HYDROCHLORIDE and ALANINE AMINOTRANSFERASE INCREASED

Overview

ALANINE AMINOTRANSFERASE INCREASED is the #14 most commonly reported adverse reaction for MEXILETINE HYDROCHLORIDE, manufactured by ANI Pharmaceuticals, Inc.. There are 14 FDA adverse event reports linking MEXILETINE HYDROCHLORIDE to ALANINE AMINOTRANSFERASE INCREASED. This represents approximately 1.3% of all 1,120 adverse event reports for this drug.

Patients taking MEXILETINE HYDROCHLORIDE who experience alanine aminotransferase increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ALANINE AMINOTRANSFERASE INCREASED is a less commonly reported adverse event for MEXILETINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.

Other Side Effects of MEXILETINE HYDROCHLORIDE

In addition to alanine aminotransferase increased, the following adverse reactions have been reported for MEXILETINE HYDROCHLORIDE:

• DRUG INEFFECTIVE — 42 reports
• FATIGUE — 31 reports
• VENTRICULAR TACHYCARDIA — 31 reports
• DYSPNOEA — 26 reports
• POOR QUALITY SLEEP — 24 reports
• IMPAIRED WORK ABILITY — 23 reports
• NAUSEA — 23 reports
• IMPAIRED QUALITY OF LIFE — 22 reports
• PYREXIA — 22 reports
• CARDIAC FAILURE — 18 reports

Other Drugs Associated with ALANINE AMINOTRANSFERASE INCREASED

The following drugs have also been linked to alanine aminotransferase increased in FDA adverse event reports:

Does MEXILETINE HYDROCHLORIDE cause ALANINE AMINOTRANSFERASE INCREASED?

ALANINE AMINOTRANSFERASE INCREASED has been reported as an adverse event in 14 FDA reports for MEXILETINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ALANINE AMINOTRANSFERASE INCREASED with MEXILETINE HYDROCHLORIDE?

ALANINE AMINOTRANSFERASE INCREASED accounts for approximately 1.3% of all adverse event reports for MEXILETINE HYDROCHLORIDE, making it a notable side effect.

What should I do if I experience ALANINE AMINOTRANSFERASE INCREASED while taking MEXILETINE HYDROCHLORIDE?

If you experience alanine aminotransferase increased while taking MEXILETINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages